NCT02523781

Brief Summary

It is known that preeclampsia is a risk factor for cardiovascular diseases, diabetes, chronic hypertension, nephropathy and thromboembolism. The study's aim, subsequent to these informations, is to help prevent those consequences. Information tools have been known to enhance retention of information given orally. The objective of this study is to assess the knowledge and satisfaction of women after an episode of preeclampsia after reading an explanatory pamphlet on preeclampsia. The investigators also want to change their perception on cardiovascular risk, their risk of recurrence and preeclampsia's medium to long-term consequences and the ways to prevent them.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 30, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 14, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 20, 2017

Completed
2.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

April 27, 2021

Status Verified

April 1, 2021

Enrollment Period

2.2 years

First QC Date

July 30, 2015

Last Update Submit

April 26, 2021

Conditions

Keywords

preeclampsiainformation pamphletpatient education

Outcome Measures

Primary Outcomes (1)

  • knowledge improvement (questionnaire with check list and true/false questions).

    The primary outcome will be the comparison of knowledge between the intervention (with the pamphlet) and the control (without the pamphlet) group at one month with a validated questionnaire (knowledge: check list and true/false questions).

    4 weeks

Secondary Outcomes (11)

  • Perception of cardiovascular risk between the intervention and the control group at one month (Likert scale)

    4 weeks

  • Anxiety between the intervention and the control group at one month.(Likert scale)

    4 weeks

  • Satisfaction between the intervention and the control group at one month.(Likert scale)

    4 weeks

  • Perception of cardiovascular risk in the intervention group between baseline and at one month (Likert scale)

    4 weeks

  • Perception of cardiovascular risk between baseline and at one month in the control group. (Likert scale)

    4 weeks

  • +6 more secondary outcomes

Study Arms (2)

Control group

NO INTERVENTION

The control group does not receive the information pamphlet

Intervention group

EXPERIMENTAL

The intervention group receives the information pamphlet

Other: information pamphlet

Interventions

The intervention group receives the information pamphlet

Intervention group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and older
  • followed at the CHUS obstetrical clinic for a 4 weeks to 18 months postpartum follow up
  • had hypertension in her last pregnancy

You may not qualify if:

  • Not able to read and write in French.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hopitalier Universiatire de Sherbrooke

Sherbrooke, Quebec, J1H 5N4, Canada

Location

MeSH Terms

Conditions

Hypertension, Pregnancy-InducedPre-Eclampsia

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Study Officials

  • Sauvé Nadine, MD

    Université de Sherbrooke

    PRINCIPAL INVESTIGATOR
  • Anne-Marie côté, MD

    Université de Sherbrooke

    STUDY CHAIR
  • Annabelle Cumyn, MD

    Université de Sherbrooke

    STUDY CHAIR
  • Marie-Eve Roy-Lacroix, MD

    Université de Sherbrooke

    STUDY CHAIR
  • Myriam Champagne, MD

    Université de Sherbrooke

    STUDY CHAIR
  • Marie-Hélène Pesant, MD

    Université de Sherbrooke

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher of the Mother-Child axis of the CRCHUS

Study Record Dates

First Submitted

July 30, 2015

First Posted

August 14, 2015

Study Start

June 1, 2015

Primary Completion

August 20, 2017

Study Completion

July 1, 2020

Last Updated

April 27, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations